Emily J. Hallberg

The <i>BRCA1</i> c. 5096G&gt;A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

Setareh Moghadasi, Huong Meeks, Maaike P.G. Vreeswijk et al. · Journal of Medical Genetics · 2017 · 85 citations · Full text

Medicine, Genetics, Oncology +17

Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer

Akiko Chiba, Tanya L. Hoskin, Emily J. Hallberg et al. · Annals of Surgical Oncology · 2016 · 65 citations · Full text

Medicine, Genetics, Oncology +16

Incidence of chronic lymphocytic leukemia and high‐count monoclonal B‐cell lymphocytosis using the 2008 guidelines

Timothy G. Call, Aaron D. Norman, Curtis A. Hanson et al. · Cancer · 2014 · 44 citations · Full text

Medicine, Hematology, Oncology +12